Literature DB >> 526721

Oxidation phenotype and metiamide metabolism [proceedings].

J R Idle, J C Ritchie, R L Smith.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 526721      PMCID: PMC2043658     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  3 in total

1.  Polymorphism of carbon oxidation of drugs and clinical implications.

Authors:  T P Sloan; A Mahgoub; R Lancaster; J R Idle; R L Smith
Journal:  Br Med J       Date:  1978-09-02

2.  Letter: Neutropenia associated with metiamide.

Authors:  J A Forrest; D J Shearman; R Spence; L R Celestin
Journal:  Lancet       Date:  1975-02-15       Impact factor: 79.321

3.  Letter: Reversal of metiamide-induced agranulocytosis during treatment with cimetidine.

Authors:  W L Burland; P C Sharpe; D G Colin-Jones; P R Turnbull; P Bowskill
Journal:  Lancet       Date:  1975-11-29       Impact factor: 79.321

  3 in total
  5 in total

1.  Contribution of the genetic status of oxidative metabolism to variability in the plasma concentrations of beta-adrenoceptor blocking agents.

Authors:  P Dayer; L Balant; A Küpfer; F Courvoisier; J Fabre
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 2.  Assessment of the drug metabolism capacity of the liver.

Authors:  B K Park
Journal:  Br J Clin Pharmacol       Date:  1982-11       Impact factor: 4.335

3.  Genetic aspects of the polymodally distributed sulphoxidation of S-carboxymethyl-L-cysteine in man.

Authors:  S C Mitchell; R H Waring; C S Haley; J R Idle; R L Smith
Journal:  Br J Clin Pharmacol       Date:  1984-10       Impact factor: 4.335

4.  Assay and characterisation of debrisoquine 4-hydroxylase activity of microsomal fractions of human liver.

Authors:  G C Kahn; A R Boobis; S Murray; M J Brodie; D S Davies
Journal:  Br J Clin Pharmacol       Date:  1982-05       Impact factor: 4.335

Review 5.  Genetically determined variability in acetylation and oxidation. Therapeutic implications.

Authors:  D W Clark
Journal:  Drugs       Date:  1985-04       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.